21 May 2013
Keywords: fda, says, sb, factive, non-approvable, smithkline, beecham
Article | 18 December 2000
SmithKline Beecham suffered another blow to its new product roll-outwith the announcement that the US Food and Drug Administration has
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 December 2000
19 December 2000
14 December 2000
© 2013 thepharmaletter.com